The global bioimpedance devices market is on a steady growth trajectory, with estimated sales of USD 650.5 million in 2024. The market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 6.7% between 2024 and 2034, reaching a valuation of USD 1,244.2 million by 2034. Revenue generated by bioimpedance devices in 2023 stood at USD 612.3 million.
Bioimpedance devices, widely used for body composition analysis, hydration status monitoring, and various diagnostic applications, are gaining traction due to their non-invasive nature and increasing demand in healthcare and fitness industries. The growing emphasis on personalized healthcare, combined with rising health awareness among individuals, is driving the adoption of these devices.
Technological advancements in bioimpedance systems are further enhancing accuracy and usability, contributing to market growth. The expanding application scope in chronic disease management, sports medicine, and wellness monitoring is expected to create significant opportunities for manufacturers in the coming decade.
Key Growth Drivers
The expansion of the bioimpedance devices market is driven by several factors:
- Rising Prevalence of Chronic Diseases: The increasing incidence of conditions such as cardiovascular disorders, diabetes, and obesity necessitates continuous monitoring of body composition and fluid levels.
- Technological Advancements: Innovations have made bioimpedance devices more accurate, user-friendly, and cost-effective, broadening their accessibility to healthcare facilities.
Market Dynamics
- The growing awareness among consumers regarding the importance of regular health check-ups and personalized healthcare is contributing to market growth.
- The effectiveness of bioimpedance devices in non-invasive body composition analysis and fluid monitoring further enhances their appeal in clinical settings.
Regional Insights
- The market is particularly strong in developed regions where healthcare infrastructure supports advanced monitoring technologies.
- Favorable government initiatives and funding for research and development in medical technologies are also boosting market growth.
Competitive Landscape
Substantial investments are seen in the bioimpedance devices industry towards research and development in order to drive innovations by differentiating products through advanced features and improved patient outcomes. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in Bioimpedance Devices Market:
- In December 2023, AMPED FITNESS® partnered with Evolt™ to bring Vip Members Top-Tier Body Composition Technology. The Evolt 360 Body Composition Scanner is a simple-to-use tool that provides detailed data about the body through more than 40 measurements in just 60 seconds. It works by passing a safe electrical current through the feet and hands to measure muscle mass, fat mass, water and minerals in a way that is specific to the individual
- Omron Corporation strategically focuses on leveraging advanced bioimpedance technology to enhance diagnostic accuracy and patient monitoring. By integrating cutting-edge innovations, expanding global partnerships, and prioritizing user-friendly, reliable solutions, Omron aims to lead the bioimpedance devices market.
A Full Report Analysis
Key Players of Bioimpedance Devices Market
- Bioparhom
- Akern
- Biodynamics Corporation
- Tanita Corporation
- Biotekna
- Omron Corporation
- InBody
- EVOLT 360
- RJL Systems
- Fook Tin Group Holding Ltd
Key Segments of Bioimpedance Devices Market
By Product:
In terms of product, the industry is divided into multi-frequency, single-frequency and dual-frequency.
By Modality:
In terms of modality, the industry is segregated into wired bioimpedance and wireless bioimpedance.
By Application:
In terms of application, the industry is segregated into whole-body measurement and segmental body measurement.
By Region:
Key countries of North America, Latin America, Western Europe, Eastern, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube